Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
BMC Cancer|February 3, 2019
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiformeSabrina Heynckes, Karam Daka, Pamela Franco, et al.Blood Advances|July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple MyelomaTim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.Nature Communications|June 13, 2019
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastomaDieter Henrik Heiland, Vidhya M Ravi, Simon P Behringer, et al.Leukemia|December 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myelomaMartin Grözinger, Muriel Schlanke, Jana Gröne, et al.Blood Advances|April 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myelomaJan Hendrik Frenking, Xiang Zhou, Kai Rejeski, et al.Nature Medicine|January 15, 2026
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myelomaHolly Lee, Sungwoo Ahn, Gerone A Gonzales, et al.Pageof 1